Improved Minicircle DNA Biosynthesis for Gene Therapy Applications

Detalhes bibliográficos
Autor(a) principal: Gaspar, V. M.
Data de Publicação: 2014
Outros Autores: Maia, C J, Queiroz, João, Pichon, Chantal, Correia, Ilídio, Sousa, Fani
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.6/4654
Resumo: Minicircular DNA (mcDNA) biopharmaceuticals have recently risen as a valuable alternative for the development of a next generation of bioactive therapeutics because they are more efficient and safer than standard plasmid DNA (pDNA). To date, the relatively insufficient knowledge regarding mcDNA biosynthesis is currently hindering its manufacture in suitable amounts for clinical trial evaluations. Addressing this limitation is therefore mandatory to bring forth the full therapeutic potential of this cutting-edge technology. Herein, we describe for the first time new processing parameters that improve the overall yield of mcDNA obtained from bacterial fermentations. We provide details for further in-line monitoring and optimization in view of the current good manufacturing guidelines. Our results show that by rising growth temperature to 42°C, an increase in the overall minicircle producer plasmid yield is attained, while biomass amounts are reduced. Moreover, by monitoring in real time the dynamic recombination of parental plasmids to mcDNA, we found that this event is more efficient at specific time points, regardless of the growth temperature and inductor concentration used. These are important findings since mcDNA can be recovered with higher yields at these determined key stages. Indeed, the manipulation of these parameters resulted in a 2.21-fold increase in mcDNA production compared with the established growth temperatures for this technology. Overall, our findings highlight that to achieve maximum productivity while attaining pharmaceutical-grade mcDNA preparations, process design and biosynthesis optimization must take into account key parameters such as temperature, inductor concentration, and recovery time.
id RCAP_bd3919fed436352c8a5cbd4e8cab4116
oai_identifier_str oai:ubibliorum.ubi.pt:10400.6/4654
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Improved Minicircle DNA Biosynthesis for Gene Therapy ApplicationsMinicircle DNABiosynthesisGene TherapyMinicircular DNA (mcDNA) biopharmaceuticals have recently risen as a valuable alternative for the development of a next generation of bioactive therapeutics because they are more efficient and safer than standard plasmid DNA (pDNA). To date, the relatively insufficient knowledge regarding mcDNA biosynthesis is currently hindering its manufacture in suitable amounts for clinical trial evaluations. Addressing this limitation is therefore mandatory to bring forth the full therapeutic potential of this cutting-edge technology. Herein, we describe for the first time new processing parameters that improve the overall yield of mcDNA obtained from bacterial fermentations. We provide details for further in-line monitoring and optimization in view of the current good manufacturing guidelines. Our results show that by rising growth temperature to 42°C, an increase in the overall minicircle producer plasmid yield is attained, while biomass amounts are reduced. Moreover, by monitoring in real time the dynamic recombination of parental plasmids to mcDNA, we found that this event is more efficient at specific time points, regardless of the growth temperature and inductor concentration used. These are important findings since mcDNA can be recovered with higher yields at these determined key stages. Indeed, the manipulation of these parameters resulted in a 2.21-fold increase in mcDNA production compared with the established growth temperatures for this technology. Overall, our findings highlight that to achieve maximum productivity while attaining pharmaceutical-grade mcDNA preparations, process design and biosynthesis optimization must take into account key parameters such as temperature, inductor concentration, and recovery time.Mary Ann LiebertuBibliorumGaspar, V. M.Maia, C JQueiroz, JoãoPichon, ChantalCorreia, IlídioSousa, Fani2018-03-20T11:29:08Z2014-04-012014-04-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.6/4654engGaspar, V.M., Maia, C.J., Queiroz, J.A., Pichon, C., Correia, I.J. e Sousa, F. (2014) "Improved minicircle dna biosynthesis for gene therapy applications", Human Gene Therapy Methods, Vol. 25(2), pp. 93-10510.1089/hgtb.2013.020metadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-12-15T09:41:51Zoai:ubibliorum.ubi.pt:10400.6/4654Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:45:42.816452Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Improved Minicircle DNA Biosynthesis for Gene Therapy Applications
title Improved Minicircle DNA Biosynthesis for Gene Therapy Applications
spellingShingle Improved Minicircle DNA Biosynthesis for Gene Therapy Applications
Gaspar, V. M.
Minicircle DNA
Biosynthesis
Gene Therapy
title_short Improved Minicircle DNA Biosynthesis for Gene Therapy Applications
title_full Improved Minicircle DNA Biosynthesis for Gene Therapy Applications
title_fullStr Improved Minicircle DNA Biosynthesis for Gene Therapy Applications
title_full_unstemmed Improved Minicircle DNA Biosynthesis for Gene Therapy Applications
title_sort Improved Minicircle DNA Biosynthesis for Gene Therapy Applications
author Gaspar, V. M.
author_facet Gaspar, V. M.
Maia, C J
Queiroz, João
Pichon, Chantal
Correia, Ilídio
Sousa, Fani
author_role author
author2 Maia, C J
Queiroz, João
Pichon, Chantal
Correia, Ilídio
Sousa, Fani
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv uBibliorum
dc.contributor.author.fl_str_mv Gaspar, V. M.
Maia, C J
Queiroz, João
Pichon, Chantal
Correia, Ilídio
Sousa, Fani
dc.subject.por.fl_str_mv Minicircle DNA
Biosynthesis
Gene Therapy
topic Minicircle DNA
Biosynthesis
Gene Therapy
description Minicircular DNA (mcDNA) biopharmaceuticals have recently risen as a valuable alternative for the development of a next generation of bioactive therapeutics because they are more efficient and safer than standard plasmid DNA (pDNA). To date, the relatively insufficient knowledge regarding mcDNA biosynthesis is currently hindering its manufacture in suitable amounts for clinical trial evaluations. Addressing this limitation is therefore mandatory to bring forth the full therapeutic potential of this cutting-edge technology. Herein, we describe for the first time new processing parameters that improve the overall yield of mcDNA obtained from bacterial fermentations. We provide details for further in-line monitoring and optimization in view of the current good manufacturing guidelines. Our results show that by rising growth temperature to 42°C, an increase in the overall minicircle producer plasmid yield is attained, while biomass amounts are reduced. Moreover, by monitoring in real time the dynamic recombination of parental plasmids to mcDNA, we found that this event is more efficient at specific time points, regardless of the growth temperature and inductor concentration used. These are important findings since mcDNA can be recovered with higher yields at these determined key stages. Indeed, the manipulation of these parameters resulted in a 2.21-fold increase in mcDNA production compared with the established growth temperatures for this technology. Overall, our findings highlight that to achieve maximum productivity while attaining pharmaceutical-grade mcDNA preparations, process design and biosynthesis optimization must take into account key parameters such as temperature, inductor concentration, and recovery time.
publishDate 2014
dc.date.none.fl_str_mv 2014-04-01
2014-04-01T00:00:00Z
2018-03-20T11:29:08Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.6/4654
url http://hdl.handle.net/10400.6/4654
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Gaspar, V.M., Maia, C.J., Queiroz, J.A., Pichon, C., Correia, I.J. e Sousa, F. (2014) "Improved minicircle dna biosynthesis for gene therapy applications", Human Gene Therapy Methods, Vol. 25(2), pp. 93-105
10.1089/hgtb.2013.020
dc.rights.driver.fl_str_mv metadata only access
info:eu-repo/semantics/openAccess
rights_invalid_str_mv metadata only access
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Mary Ann Liebert
publisher.none.fl_str_mv Mary Ann Liebert
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136354459713536